1. Home
  2. ABEO vs FTF Comparison

ABEO vs FTF Comparison

Compare ABEO & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.05

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Logo Franklin Limited Duration Income Trust of Beneficial Interest

FTF

Franklin Limited Duration Income Trust of Beneficial Interest

HOLD

Current Price

$6.11

Market Cap

256.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABEO
FTF
Founded
1974
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
281.0M
256.6M
IPO Year
1980
N/A

Fundamental Metrics

Financial Performance
Metric
ABEO
FTF
Price
$5.05
$6.11
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$18.20
N/A
AVG Volume (30 Days)
2.8M
153.9K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
11.45%
EPS Growth
N/A
N/A
EPS
1.29
N/A
Revenue
$400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$324.71
N/A
P/E Ratio
$3.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.93
$5.76
52 Week High
$7.54
$6.56

Technical Indicators

Market Signals
Indicator
ABEO
FTF
Relative Strength Index (RSI) 56.25 48.07
Support Level $4.37 $5.96
Resistance Level $5.17 $6.17
Average True Range (ATR) 0.32 0.04
MACD 0.12 0.01
Stochastic Oscillator 65.80 70.73

Price Performance

Historical Comparison
ABEO
FTF

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About FTF Franklin Limited Duration Income Trust of Beneficial Interest

Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.

Share on Social Networks: